D. Reymen et al., MECHANISM OF THE ANTIVIRAL ACTIVITY OF NEW AURINTRICARBOXYLIC ACID ANALOGS, Antiviral chemistry & chemotherapy, 7(3), 1996, pp. 142-152
Various new aurintricarboxylic acid (ATA) polymer analogues have been
evaluated for their antiviral activity against a wide array of DNA and
RNA viruses, and their mechanism of action against human cytomegalovi
rus (HCMV) and human immunodeficiency virus type 1 (HIV-1). Most of th
e polymers exhibited marked antiviral activity against a variety of en
veloped viruses, but not against non-enveloped viruses, The ATA polyme
rs displayed the most pronounced activity against HIV-1, HCMV and huma
n herpesvirus type 6 (HHV-6), Their action against HCMV and HIV could
be ascribed to inhibition of the initial attachment of virus particles
to the cells, Using radiolabelled virus, we proved that the polymers
inhibit the binding of HCMV to HEL fibroblasts, By flow cytometric ana
lysis, we demonstrated that these new polymers interfere with (i) the
binding of OKT4A monoclonal antibody (mAb) to the cellular CD4 recepto
r, (ii) the binding of anti-gp120 mAb to HIV-1 glycoprotein (gp) 120,
and (iii) the adsorption of HIV-1 virions and recombinant HIV-1gp120 (
rgp120) to MT-4 cells, The presence of a salicylic acid substituent on
the central bridging carbon in the parent compound ATA seems to play
an important role in the anti-HIV activity of these ATA related polyme
r analogues.